COVID-19 R&D services

In response to the COVID-19 pandemic, Biotechnology R&D has created tools adapted to SARS-CoV-2: in vitro assays on Vero E6, Caco-2, Calu-3 models or ex vivo on epithelial airway explants (HAE), in vivo tests on hACE2 humanized mice or on golden hamster, with the use of original, alpha, delta or omicron variants, for the development of COVID-19 drugs, vaccines, validation of immunological, PCR or side-flow diagnostic kits, measurement of virucidal effects of materials directly on SARS-CoV-2.

15 - Drug Discovery

COVID-19 Drug Development

In vitro assays
In vivo assays & models
In silico assay
Cytometry
Antibody production
SARS-CoV-2 samples
Compound screening and synthesis
Immunological analysis
Virucidal activity
Biostatistics & bioinformatics
NGS sequencing
Clinical study
Regulatory preclinical studies
Consulting
On-demand sample storage
21 - MS-1

COVID-19 Vaccine Development

In vitro assays
In vivo assessment
Protein production
Immunogenicity analysis
In silico assay
Biostatistics & bioinformatics
SARS-CoV-2 samples
Consulting
COVID-19 peptide array
183 - Test-Culture-Cell

SARS-CoV-2 Diagnostics Kits Development

Antibody production
Protein production
qPCR & dPCR
Coronavirus & patients samples
In silico development
Consulting
COVID-19 peptide array
Samples DNA extraction & storage
favicon large-1

    Discover all our service categories: